The effect of radiation therapy on normal tissue function
dc.contributor.author | FitzGerald, Thomas J | |
dc.contributor.author | Aronowitz, Jesse N. | |
dc.contributor.author | Cicchetti, Maria Giulia | |
dc.contributor.author | Fisher, Graeme | |
dc.contributor.author | Kadish, Sidney P. | |
dc.contributor.author | Lo, Y C. | |
dc.contributor.author | Mayo, Charles | |
dc.contributor.author | McCauley, Shelagh | |
dc.contributor.author | Meyer, Joshua | |
dc.contributor.author | Pieters, Richard S. | |
dc.contributor.author | Sherman, Alexandra | |
dc.date | 2022-08-11T08:10:32.000 | |
dc.date.accessioned | 2022-08-23T17:12:25Z | |
dc.date.available | 2022-08-23T17:12:25Z | |
dc.date.issued | 2006-02-01 | |
dc.date.submitted | 2017-04-21 | |
dc.identifier.citation | <p>Hematol Oncol Clin North Am. 2006 Feb;20(1):141-63. <a href="https://doi.org/10.1016/j.hoc.2006.01.005">Link to article on publisher's site</a></p> | |
dc.identifier.issn | 0889-8588 (Linking) | |
dc.identifier.doi | 10.1016/j.hoc.2006.01.005 | |
dc.identifier.pmid | 16580561 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/46498 | |
dc.description.abstract | As more patients are treated for their primary malignancy with cure or increased disease-free intervals, injury to normal tissues will become more detectable and an important endpoint for study. Future protocols will probably be modified based on toxicity endpoints. In Hodgkin's disease, current protocols use response-based treatment strategies to limit therapy. The objective is to provide the same level of tumor control and follow normal tissue endpoints for outcome analysis. DVH analysis has improved the ability to analyze endpoint data for normal tissues. These image-guided platforms will provide the infrastructure needed to continue efforts in improving the delivery of radiation therapy. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=16580561&dopt=Abstract">Link to Article in PubMed</a></p> | |
dc.relation.url | http://dx.doi.org/10.1016/j.hoc.2006.01.005 | |
dc.subject | Health Services Administration | |
dc.subject | Neoplasms | |
dc.subject | Oncology | |
dc.subject | Radiology | |
dc.subject | Therapeutics | |
dc.subject | Tissues | |
dc.title | The effect of radiation therapy on normal tissue function | |
dc.type | Journal Article | |
dc.source.journaltitle | Hematology/oncology clinics of North America | |
dc.source.volume | 20 | |
dc.source.issue | 1 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/qarc/49 | |
dc.identifier.contextkey | 10059147 | |
html.description.abstract | <p>As more patients are treated for their primary malignancy with cure or increased disease-free intervals, injury to normal tissues will become more detectable and an important endpoint for study. Future protocols will probably be modified based on toxicity endpoints. In Hodgkin's disease, current protocols use response-based treatment strategies to limit therapy. The objective is to provide the same level of tumor control and follow normal tissue endpoints for outcome analysis. DVH analysis has improved the ability to analyze endpoint data for normal tissues. These image-guided platforms will provide the infrastructure needed to continue efforts in improving the delivery of radiation therapy.</p> | |
dc.identifier.submissionpath | qarc/49 | |
dc.contributor.department | Department of Radiation Oncology | |
dc.contributor.department | Quality Assurance Review Center | |
dc.source.pages | 141-63 |